Modern research into physiology of varying origin stem cells and into technologies of isolation, cultivation, genetic transformation and cryoconcervation of cells and tissues have promoted the appearance of newest methods of diagnosis and treatment of obstetric and gynecological diseases, hypoxic-ischemic new-born encephalopathy and children cerebral palsy.
It is common knowledge that some diseases developing in women before and during pregnancy, inborn diseases of babies and obstetric aggression may lead to severe consequences in the new-born like hypoxic-ischemic encephalopathy which at remote period causes children cerebral palsy.
Positive results obtained both, in experiment and in clinic, have already been demonstrated when using stem cells of varying origin, including autologic and allogenic umbilical cord blood, containing various type stem cells.
A wide introduction of cellular therapy methods in clinical practice will bring about new opportunities for physicians in treating socially significant diseases, namely: infertility, hypoxic-ischemic encephalopathy, children cerebral palsy, etc.
Specialists working in obstetrics, gynecology, neonatology, pediatric neurology, cell biology, cryobiology, physicians and other specialists are invited to take part in this conference.
+ show speakers and program
Confirmed speakers:
Stem Cells for Acute Neonatal Hypoxic-Ischemic Injury.
James Carroll, MD, Professor and Chief Child Neurology, Georgia Regents University, Augusta, USA

Umbilical Cord Blood Therapy Potentiated with Erythropoietin for Children with Cerebral Palsy.
MinYoung Kim, Director of Rehabilitation Medicine Department, CHA University, Seongnam-si, South Korea

Famicord Group experience in haematopoietic and mesenchymal stem cells transplantation.
Dariusz Boruczkowski, Famicord Group, Warszawa, Poland

7 Nov - 7 Nov 2013
meeting website